Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Schoeneck | M | 66 | 14 years | |
| Thane Wettig | M | 59 | 4 years | |
| Jeffrey Edwards | M | 64 | 9 years | |
| Aoife Brennan | M | 48 | 4 years | |
| Jeffrey Henderson | M | 59 | 9 years | |
| Suzanne Blaug | F | 66 | 5 years | |
| Gerald Lema | M | 63 | 7 years | |
| Benjamin Cravatt | M | 54 | 4 years | |
| May Kin Ho | M | 71 | 6 years | |
| Meichiel Keenan | F | - | 20 years | |
| Kirk A. Christoffersen | M | 56 | 4 years | |
| Michael D. Lowenstein | M | - | 21 years | |
| Elias Kouchakji | M | 67 | 10 years | |
| Christine Chung L. | F | 56 | 17 years | |
| John Hunter | M | 61 | 3 years | |
| Juan Graham | M | 48 | 3 years | |
| Tricia Stewart | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Barrett | M | 81 |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | 8 years |
| Michael Perry | M | 64 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 6 years |
| Julian N. Stern | M | 99 | 25 years | |
| Thomas Byron Neff | M | 69 | 26 years | |
| Patricio Miguel Madero Blasquez | M | 74 | 20 years | |
| Kalevi Kurkijärvi | M | 72 | 25 years | |
| Marc R. Schneebaum | M | 69 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | 6 years |
| Toshinari Tamura | M | 80 | 12 years | |
| Karen L. Bergman | F | - | - | |
| Enrique Conterno | M | 57 | 3 years | |
| Roberto Pedro Rosenkranz | M | 74 | 10 years | |
| Carol C. Grundfest | F | 69 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 2 years |
| Michael D. Casey | M | 78 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | 2 years |
| Michael P. Cooke | M | 62 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 6 years |
| Greg Mann | M | - | - | |
| Paul J. Frohna | M | - | 1 years | |
| Laura G. Hansen | M | - | 10 years | |
| Anne-Marie O'Farrell | M | - |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 2 years |
| François Meyer | M | 76 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 3 years |
| Mark Eisner | M | 58 | 3 years | |
| Carolyn Provost | F | - |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 7 years |
| Percy Carter | M | 53 | 1 years | |
| Michael Martinelli | M | - | 11 years | |
| Gerd Kochendoerfer | M | 56 | 3 years | |
| Christopher J. Molineaux | M | 70 | 4 years | |
| Seth Porter | M | - | 13 years | |
| Brain Roberts | M | 49 | 5 years | |
| David Gearing | M | 62 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 1 years |
| Mark P. Backer | M | - |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 3 years |
| Kalyanasundaram Subramanian | M | - |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | 3 years |
| Stewart Craig | M | 63 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 2 years |
| Audrey F. Jakubowski | M | 81 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 2 years |
| Russell Ellison | M | 76 | 2 years | |
| Frank Valone | M | 74 | 8 years | |
| Cindy M. Domecus | F | 64 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 2 years |
| James M. Frincke | M | 73 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 4 years |
| Didier L. Lanson | M | 74 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 7 years |
| David Liu | M | 73 | 8 years | |
| Thomas Callaway | M | - |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 2 years |
| Rachel King | F | 64 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | 2 years |
| R. Wayne Frost | M | 69 | - | |
| Claire J. Lockey | F | 71 | 7 years | |
| Grace U. Shin | F | 59 | 9 years | |
| Richard A. Farley | M | - | 6 years | |
| Sarah O'Dowd | F | 74 | 1 years | |
| Kin Hung Yu | M | 61 | 12 years | |
| Zhi Feng Long | M | 62 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 64 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Pat Cotroneo
- Personal Network
